China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $227,809 | $235,618 | – | $2,117,858 |
| % Growth | -3.3% | – | – | – |
| Cost of Goods Sold | $63,282 | $60,151 | – | $527,696 |
| Gross Profit | $164,528 | $175,467 | – | $1,590,162 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| R&D Expenses | $6,944 | $7,770 | – | $62,264 |
| G&A Expenses | $0 | $0 | – | $188,131 |
| SG&A Expenses | $106,476 | $129,329 | – | $1,143,808 |
| Sales & Mktg Exp. | $0 | $0 | – | $956,473 |
| Other Operating Expenses | $0 | $0 | – | $0 |
| Operating Expenses | $113,420 | $137,099 | – | $1,067,535 |
| Operating Income | $51,108 | $38,368 | – | $384,090 |
| % Margin | 22.4% | 16.3% | – | 18.1% |
| Other Income/Exp. Net | $55,674 | $1,145 | – | $184,875 |
| Pre-Tax Income | $106,782 | $39,513 | – | $568,965 |
| Tax Expense | $22,057 | $9,761 | – | $90,920 |
| Net Income | $84,726 | $29,752 | – | $478,045 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS | 44.8 | 15.8 | – | 252 |
| % Growth | 183.5% | – | – | – |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| Weighted Avg Shares Out | 1,889 | 1,889 | – | 1,897 |
| Weighted Avg Shares Out Dil | 1,889 | 1,889 | – | 1,889 |
| Supplemental Information | – | – | – | – |
| Interest Income | $16,516 | $8,381 | – | $46,338 |
| Interest Expense | $808 | $457 | – | $0 |
| Depreciation & Amortization | $10,191 | $10,241 | – | $79,784 |
| EBITDA | $117,782 | $50,210 | – | $463,874 |
| % Margin | 51.7% | 21.3% | – | 21.9% |